UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 8, 2025 Trevi Therapeutics, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-38886 45-0834299 (State or Other Jurisdiction of Incorporation) (Commission File Number) Registrant's telephone number, including area code: (203) 304-2499 (IRS Employer Identification No.) Not appli ...